Market Tracker

10/31 6:27am ET

Emergent BioSolutions Inc (NYSE:EBS)

22.35
Data as of Oct 30
 +0.44 / +2.01%
Today’s Change
18.28
Today|||52-Week Range
28.48
-2.78%
Year-to-Date

Today’s Trading

Previous close21.91
Today’s open21.89
Day’s range-- - --
Volume222,550
Average volume (3 months)209,070
Market cap$821.1M
Dividend yield--
Data as of 10/30/2014

Growth & Valuation

Earnings growth (last year)+30.77%
Earnings growth (this year)-1.76%
Earnings growth (next 5 years)+31.00%
Revenue growth (last year)+10.95%
P/E ratio1,117.5
Price/Sales2.66
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.76+3.07%
ENTAEnanta Pharmaceutica...-0.08-0.18%
RGLSRegulus Therapeutics...+0.22+1.22%
ASPXAuspex Pharmaceutica...-0.12-0.44%
Data as of 10/30/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$0.46
Annual revenue (last year)$312.7M
Annual profit (last year)$31.1M
Net profit margin9.96%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts